BA-2101

N/A

Report date: 2024/04/08 14:43:01

Base Information

Drug NameBA-2101
Drug Alias NameBA-2101BA2101PR-103PR103
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionInterleukin-4 receptor subunit alpha inhibitors
TargetsInterleukin-4 receptor subunit alpha
Therapy Area/IndicationsChronic UrticariaUrticariaPruritus +[9] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesShandong Boan Biotechnology Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesShandong Boan Biotechnology Co LtdJoincare Pharmaceutical Group Industry Co Ltd
Inactive CompaniesN/A
Active IndicationsChronic UrticariaUrticariaPruritus +[9] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A